Police probe Novo Nordisk for late disclosure of drug setback

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
(Reuters) - Novo Nordisk, the world's largest insulin maker, has been reported to the police by Denmark's financial watchdog for not disclosing at once that its big new product hope Tresiba had been refused U.S. approval.

The Danish Financial Supervisory Authority (FSA) said the company should have issued a statement about the U.S. decision not to approve its new long-acting insulin on the evening of Friday, February 8, and not wait until Sunday, February 10, as it did.

The news that the Food and Drug Administration (FDA) had declined to approve Tresiba and a related combination drug called Ryzodeg was a major blow to Novo and confounded expectations of investors, who had expected a green light.

http://uk.reuters.com/article/2013/12/10/us-novo-police-idUKBRE9B907J20131210
 
Good grief, that's a bit OTT, surely?

Personally on a weekend, I wouldn't have expected anything until lunchtime Monday at the earliest!
 
Considering the saturation coverage, fuss, and bother over Nelson Bloody Mandela I'm surprised that any other events penetrated the news services over the past few days
 
Status
Not open for further replies.
Back
Top